Sustained Release Excipients Market Size, Share, Trends, Growth Outlook

Sustained Release Excipients Market is estimated to increase at a growth rate of 8.8% CAGR over the forecast period from 2024 to 2030.

The global Sustained Release Excipients Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan), By Technology (Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation, Others), By Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Others).

An introduction to Sustained Release Excipients Market in 2024

The sustained release excipients market is witnessing significant growth in 2024, driven by the increasing demand for extended-release formulations, advancements in drug delivery technologies, and the growing focus on patient compliance and dosing convenience in pharmaceutical product development. Sustained release excipients are pharmaceutical ingredients used to modulate drug release kinetics, control drug solubility, and enhance drug stability in modified-release dosage forms such as tablets, capsules, and transdermal patches, allowing for prolonged drug action, reduced dosing frequency, and improved therapeutic outcomes for patients. With innovations in polymer chemistry, matrix formulations, and drug encapsulation techniques, the market is experiencing rapid expansion and adoption of sustained release excipients, offering pharmaceutical companies, formulators, and drug developers versatile and customizable solutions for controlled drug delivery, bioavailability enhancement, and patient-centric dosage regimens, driving advancements in pharmaceutical formulation science and drug delivery optimization.

Sustained Release Excipients Market Trend: Demand for Biodegradable and Biocompatible Excipients:

A significant trend in the Sustained Release Excipients Market is the increasing demand for biodegradable and biocompatible excipients. With growing concerns about patient safety, drug efficacy, and environmental sustainability, there's a rising preference for excipients derived from natural sources or synthetic polymers that are biodegradable and well-tolerated by the body. This trend is driven by the need for sustained-release formulations that provide controlled drug release over extended periods while minimizing adverse effects and improving patient compliance. Manufacturers are focusing on developing excipients with enhanced biodegradability, biocompatibility, and controlled release properties to meet the evolving needs of pharmaceutical companies for sustainable and patient-friendly formulations.

Sustained Release Excipients Market Driver: Rise in Chronic Diseases and Long-acting Formulations:

The rise in chronic diseases and the demand for long-acting formulations serves as a major driver for the Sustained Release Excipients Market. As the global population ages and lifestyles change, there's an increasing prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancer that require long-term medication management. Additionally, there's a growing interest in long-acting formulations that reduce dosing frequency, improve treatment adherence, and enhance patient convenience. This trend is driving market growth as pharmaceutical companies invest in sustained-release formulations that deliver therapeutic agents at controlled rates, prolonging drug action and reducing the need for frequent dosing, thus addressing the unmet medical needs of patients with chronic diseases.

Sustained Release Excipients Market Opportunity: Development of Targeted and Site-specific Delivery Systems:

An opportunity exists for market expansion through the development of targeted and site-specific delivery systems. With advancements in drug delivery technology and personalized medicine, there's potential to innovate and introduce sustained-release excipients that enable targeted drug delivery to specific tissues or organs within the body. Manufacturers can explore the use of targeting ligands, nanoparticles, and hydrogels to create delivery systems that release drugs at precise locations, reducing systemic side effects and improving therapeutic efficacy. By offering targeted and site-specific delivery systems, companies can address the challenges of drug localization, tissue specificity, and therapeutic optimization, thus unlocking new growth opportunities in the Sustained Release Excipients Market. This strategic opportunity aligns with the broader trend towards precision medicine and individualized treatment approaches, addressing the evolving needs of pharmaceutical developers for advanced excipients that support targeted drug delivery and improve patient outcomes.

Sustained Release Excipients Market Market Segmentation

By Product
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Micro Encapsulation
Wurster Technique
Transdermal
Implants
Coacervation
Others
By Route of Administration
Oral
Intramuscular
Subcutaneous
Transdermal
Vaginal
Ophthalmic
Intravenous
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Sustained Release Excipients Market Companies

Allergan PLC
AstraZeneca
GlaxoSmithKline PLC
Mayne Pharma Group Ltd
Mylan NV
Novartis AG
Pfizer Inc
Salix Pharmaceuticals
Sun Pharmaceutical Industries Ltd

Reasons to Buy the Sustained Release Excipients Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Sustained Release Excipients Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Sustained Release Excipients Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Sustained Release Excipients Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Sustained Release Excipients Market Size Outlook, $ Million, 2021 to 2030
3.2 Sustained Release Excipients Market Outlook by Type, $ Million, 2021 to 2030
3.3 Sustained Release Excipients Market Outlook by Product, $ Million, 2021 to 2030
3.4 Sustained Release Excipients Market Outlook by Application, $ Million, 2021 to 2030
3.5 Sustained Release Excipients Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Sustained Release Excipients Industry
4.2 Key Market Trends in Sustained Release Excipients Industry
4.3 Potential Opportunities in Sustained Release Excipients Industry
4.4 Key Challenges in Sustained Release Excipients Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Sustained Release Excipients Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Sustained Release Excipients Market Outlook by Segments
7.1 Sustained Release Excipients Market Outlook by Segments, $ Million, 2021- 2030
By Product
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Micro Encapsulation
Wurster Technique
Transdermal
Implants
Coacervation
Others
By Route of Administration
Oral
Intramuscular
Subcutaneous
Transdermal
Vaginal
Ophthalmic
Intravenous
Others

8 North America Sustained Release Excipients Market Analysis and Outlook To 2030
8.1 Introduction to North America Sustained Release Excipients Markets in 2024
8.2 North America Sustained Release Excipients Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Sustained Release Excipients Market size Outlook by Segments, 2021-2030
By Product
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Micro Encapsulation
Wurster Technique
Transdermal
Implants
Coacervation
Others
By Route of Administration
Oral
Intramuscular
Subcutaneous
Transdermal
Vaginal
Ophthalmic
Intravenous
Others

9 Europe Sustained Release Excipients Market Analysis and Outlook To 2030
9.1 Introduction to Europe Sustained Release Excipients Markets in 2024
9.2 Europe Sustained Release Excipients Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Sustained Release Excipients Market Size Outlook by Segments, 2021-2030
By Product
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Micro Encapsulation
Wurster Technique
Transdermal
Implants
Coacervation
Others
By Route of Administration
Oral
Intramuscular
Subcutaneous
Transdermal
Vaginal
Ophthalmic
Intravenous
Others

10 Asia Pacific Sustained Release Excipients Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Sustained Release Excipients Markets in 2024
10.2 Asia Pacific Sustained Release Excipients Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Sustained Release Excipients Market size Outlook by Segments, 2021-2030
By Product
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Micro Encapsulation
Wurster Technique
Transdermal
Implants
Coacervation
Others
By Route of Administration
Oral
Intramuscular
Subcutaneous
Transdermal
Vaginal
Ophthalmic
Intravenous
Others

11 South America Sustained Release Excipients Market Analysis and Outlook To 2030
11.1 Introduction to South America Sustained Release Excipients Markets in 2024
11.2 South America Sustained Release Excipients Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Sustained Release Excipients Market size Outlook by Segments, 2021-2030
By Product
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Micro Encapsulation
Wurster Technique
Transdermal
Implants
Coacervation
Others
By Route of Administration
Oral
Intramuscular
Subcutaneous
Transdermal
Vaginal
Ophthalmic
Intravenous
Others

12 Middle East and Africa Sustained Release Excipients Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Sustained Release Excipients Markets in 2024
12.2 Middle East and Africa Sustained Release Excipients Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Sustained Release Excipients Market size Outlook by Segments, 2021-2030
By Product
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Micro Encapsulation
Wurster Technique
Transdermal
Implants
Coacervation
Others
By Route of Administration
Oral
Intramuscular
Subcutaneous
Transdermal
Vaginal
Ophthalmic
Intravenous
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Allergan PLC
AstraZeneca
GlaxoSmithKline PLC
Mayne Pharma Group Ltd
Mylan NV
Novartis AG
Pfizer Inc
Salix Pharmaceuticals
Sun Pharmaceutical Industries Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
By Technology
Targeted Delivery
Micro Encapsulation
Wurster Technique
Transdermal
Implants
Coacervation
Others
By Route of Administration
Oral
Intramuscular
Subcutaneous
Transdermal
Vaginal
Ophthalmic
Intravenous
Others